Submitted:
25 July 2025
Posted:
28 July 2025
You are already at the latest version
Abstract
Keywords:
1. Introduction

1.1. Assessing Prediction Sensitivity to Inflow Velocity Profiles
1.2. Prediction Sensitivity to Blood Viscosity Models
1.3. Prediction Sensitivity to Hemolysis Power-Law Constants
1.4. Prediction Sensitivity to Eulerian and Lagrangian Formulations of the Hemolysis Power-Law
2. Methods
3. Results and Discussion
3.1. Mesh Convergence and Velocity Profiles
3.2. Hemolysis Assessments
5. Conclusions
- At laminar, fully developed flow conditions, both Newtonian and non-Newtonian models showed identical shear stress variations with Reynolds number.
- When fully developed flow conditions persist throughout the geometry, absolute hemolysis predictions (in both Eulerian and Lagrangian formulations) were proportional to each other and independent of the blood viscosity model or the hemolysis power law coefficients. However, the value of the proportionality constant was specific to the power law coefficients employed in the analysis. The value of the proportionality constant was also different for the Casson non-viscosity model.
- While recent studies [7] have suggested that due to the erroneous treatment of residence time in the Eulerian formulation (resulting from flow acceleration) may necessitate the formulation/deduction of separate sets of coefficients for each (Eulerian/Lagrangian) formulation, the results from this study suggest that this requirement may be alleviated for relative hemolysis assessments when the conditions of fully developed flow are present since Eulerian and Lagrangian absolute hemolysis predictions are simply proportional to each other.
- Even when developing flow conditions persist throughout the geometry, identical variations in absolute hemolysis as a function of wall shear stresses was observed between the Eulerian and Lagrangian frameworks that was generally independent of the viscosity model. Therefore, in simple geometries similar to the ones investigated in this study (capillary tubes, FDA benchmark nozzle) where hemolysis is dominated by wall shear and hemolysis in recirculation regions are absent, the simplified Lagrangian hemolysis modeling methodology formulated based on fully developed Newtonian fluid flow could be a employed as a surrogate for quick relative hemolysis assessments. This could be done by generating an absolute hemolysis versus shear stress curve apriori using any sets of power law coefficients of choice. Next, wall shear stress values could be obtained from CFD simulations for different design prototypes or flow situations and relative hemolysis assessments made based on the curve.
Author Contributions
Funding
Data Availability Statement
Conflicts of Interest
References
- Kameneva, M.V., Burgreen, G.W., Kono, K., Repko, B., Antaki, J.F. and Umezu, M., 2004. Effects of turbulent stresses upon mechanical hemolysis: experimental and computational analysis. ASAIO journal, 50(5), pp.418-423.
- Hariharan, P., M. Giarra, V. Reddy, S. Day, K. B. Manning, S. Deutsch, S. F. C. Stewart, M. R. Myers, M. R. Berman, G. W. Burgreen, E. G. Paterson, and R. A. Malinauskas. Experimental particle image velocimetry protocol and results database for validating computational fluid dynamic simulations of the FDA benchmark nozzle model. J. Biomech. Eng. 2011, 133(4). [CrossRef]
- Stewart, S.F.C., Hariharan, P., Paterson, E.G. et al. Results of FDA’s First Interlaboratory Computational Study of a Nozzle with a Sudden Contraction and Conical Diffuser. Cardiovasc Eng Tech, 2013, Vol. 4, 374–391. [CrossRef]
- Stewart, S. F. C., Paterson, E. G., Burgreen, G. W., Hariharan, P., Giarra, M., Reddy, V., Day, S. W., Manning, K. B., Deutsch, S., Berman, M. R., Myers, M. R., & Malinauskas, R. A. Assessment of CFD performance in simulations of an idealized medical device: Results of FDA’s first computational Interlaboratory study. Cardiovascular Engineering and Technology, 2012, 3(2), 139-160. [CrossRef]
- Herbertson, L. H., Olia, S. E., Daly, A., Noatch, C. P., Smith, W. A., Kameneva, M. V., & Malinauskas, R. A. Multilaboratory study of flow-induced Hemolysis using the FDA benchmark nozzle model. Artificial Organs, 2014, 39(3), 237-248. [CrossRef]
- Mantegazza, A., Tobin, N., Manning, K.B. and Craven, B.A., 2023. Examining the universality of the hemolysis power law model from simulations of the FDA nozzle using calibrated model coefficients. Biomechanics and modeling in mechanobiology, 22(2), pp.433-451.
- Faghih, M.M., Craven, B.A. and Sharp, M.K., 2023. Practical implications of the erroneous treatment of exposure time in the Eulerian hemolysis power law model. Artificial Organs, 47(9), pp.1531-1538.
- Menon, K., Hu, Z. and Marsden, A.L., 2024. Cardiovascular fluid dynamics: a journey through our circulation. Flow, 4, p.E7.
- Kopernik, M., Modelling of blood thrombosis at microscopic and mesoscopic scales. Computer Assisted Methods in Engineering and Science, 2019, 25(1), pp.21-45.
- Giersiepen, M., Wurzinger, L.J., Opitz, R. and Reul, H., 1990. Estimation of shear stress-related blood damage in heart valve prostheses-in vitro comparison of 25 aortic valves. The International journal of artificial organs, 13(5), pp.300-306.
- Craven, B.A., Aycock, K.I., Herbertson, L.H. et al. A CFD-based Kriging surrogate modeling approach for predicting device-specific hemolysis power law coefficients in blood-contacting medical devices. Biomech Model Mechanobiol, 2019, Vol 18, 1005–1030. [CrossRef]
- Stiehm, M., Wüstenhagen, C., Siewert, S., Grabow, N. and Schmitz, K.P., 2017. Numerical simulation of pulsatile flow through a coronary nozzle model based on FDA’s benchmark geometry. Current Directions in Biomedical Engineering, 3(2), pp.775-778.
- Good, Bryan C. ‘The Effects of non-Newtonian Blood Modeling and Pulsatility on Hemodynamics in the Food and Drug Administration’s Benchmark Nozzle Model’ Biorheology 59 (2022/2023) 1–18 1, DOI 10.3233/BIR-201019.
- Trias, M., Arbona, A., Massó, J., Miñano, B., & Bona, C. FDA’s nozzle numerical simulation challenge: Non-Newtonian fluid effects and blood damage. PLOS ONE, 2014, 9(3), e92638. [CrossRef]
- Hussein, B.K.; Al-Azawy, M.G.; Al-Waaly, A.A.; Hamza, Z.A. Evaluation of Turbulence and Non-Newtonian Blood Rheology Models Through FDA Nozzle. In 2021 International Conference on Advance of Sustainable Engineering and its Application (ICASEA); IEEE: 2021, pp. 1-5.
- Zakaria, M.S., Zainudin, S.H., Abdullah, H., Yuan, C.S., Abd Latif, M.J. and Osman, K., 2019. CFD Simulation of Non-Newtonian Effect on Hemodynamics Characteristics of Blood Flow through Benchmark Nozzle. Journal of Advanced Research in Fluid Mechanics and Thermal Sciences, 64(1), pp.117-125.
- Krishnamoorthy, G. and Gholizadeh, N., 2024. Blood Damage Analysis within the FDA Benchmark Nozzle Geometry at Laminar Conditions: Prediction Sensitivities to Software and Non-Newtonian Viscosity Models. Symmetry, 16(9), p.1165.
- ANSYS Inc. ANSYS Fluent. Version 2023 R2, ANSYS Inc., 2023. https://www.ansys.com/products/fluids/ansys-fluent.
- McCabe, Warren Lee, Julian Cleveland Smith, and Peter Harriott. Unit operations of chemical engineering. Vol. 5. New York: McGraw-hill, 1967.
- Metzner, A.B. and Reed, J.C., 1955. Flow of non-newtonian fluids—correlation of the laminar, transition, and turbulent-flow regions. Aiche journal, 1(4), pp.434-440.











| Type | Viscosity Model | Constants |
| Carreau-Yasuda (CY) | ||
| Casson | ||
| Cross | ||
| Power Law | n = 0.7755 | |
| λ = 0.01467 | ||
| Model Name | Constants Source | a | b | C |
| Model I | Giersiepen et al. [10] | 0.785 | 2.416 | 3.620x10-7 |
| Model II* | Craven et al. [11], (ξ = 0.5) | 0.5 | 2.65 | 2.88x10-10 |
| Model III* | Craven et al. [11], (ξ = 0.75) | 0.7375 | 2.9 | 1.81x10-10 |
| Model IV* | Craven et al. [11], (ξ = 1.0) | 1.0 | 3.1 | 1.5x10-10 |
| Geometry | Viscosity model |
Power law constants (Table 2) |
Shear stress ranges (Pa) | Average exposure time (s) ranges* |
| Straight capillary tube (hemolysis from inlet to outlet) |
Newtonian (0.002 Pa-s, 0.0063 Pa-s), Casson | Model II, III, IV | 10 - 600 | 5.8 x 10-3 to 93 x 10-3 |
| FDA nozzle forward flow (hemolysis from inlet to outlet across the throat only) |
Newtonian (0.0035 Pa-s), 5 Non-Newtonian (Table 1, Figure 3) | Model I | 1 - 20 | 24 x 10-3 to 386 x 10-3 |
| FDA nozzle reverse flow (hemolysis from inlet to outlet across the throat only) |
Newtonian (0.0035 Pa-s), 5 Non-Newtonian (Table 1, Figure 3) | Model I | 1 - 20 | 24 x 10-3 to 386 x 10-3 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).